All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors
about
Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanismsTrace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical ImplicationsA Role for Estrogen in Schizophrenia: Clinical and Preclinical FindingsFollowing the genes: a framework for animal modeling of psychiatric disordersA conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathologyExcited Delirium and Sudden Death: A Syndromal Disorder at the Extreme End of the Neuropsychiatric ContinuumMaking Sense of: Sensitization in SchizophreniaCurrent Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive ReviewTetraspanin (TSP-17) protects dopaminergic neurons against 6-OHDA-induced neurodegeneration in C. elegansEffect of C-Terminal S-Palmitoylation on D2 Dopamine Receptor Trafficking and StabilitySchizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mousePsychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Animal Models of Psychosis: Current State and Future Directions.Epigenetic reprogramming of cortical neurons through alteration of dopaminergic circuits.Chronic Toxoplasma gondii in Nurr1-null heterozygous mice exacerbates elevated open field activityThe role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.Reward processing in autism: a thematic series.Does tobacco use cause psychosis? Systematic review and meta-analysisLY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801-induced working memory impairment.A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia.Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex.Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data.Is schizophrenia a dopamine supersensitivity psychotic reaction?Mutation of Elfn1 in mice causes seizures and hyperactivity.Imaging of thalamocortical dysrhythmia in neuropsychiatry.Effects on resting cerebral blood flow and functional connectivity induced by metoclopramide: a perfusion MRI study in healthy volunteers.Age-dependent changes in cocaine sensitivity across early ontogeny in male and female rats: possible role of dorsal striatal D2(High) receptors.Striatal dopamine receptor plasticity in neurotensin deficient mice.An update of safety of clinically used atypical antipsychotics.Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial.Transient activation of dopaminergic neurons during development modulates visual responsiveness, locomotion and brain activity in a dopamine ontogeny model of schizophrenia.Striatal development involves a switch in gene expression networks, followed by a myelination event: implications for neuropsychiatric disease.Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI.Pharmacokinetic-pharmacodynamic modeling of severity levels of extrapyramidal side effects with markov elements.Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study.The nature of dopamine dysfunction in schizophrenia and what this means for treatment.Dopamine receptor homooligomers and heterooligomers in schizophreniaSynapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs.
P2860
Q21260315-35D206C4-638D-41EE-A549-D863488AB9D7Q26745506-FE835895-C20D-4369-B177-1CC367C7C579Q26752602-F5AC4BE7-088E-4071-9015-6DDAB4255A16Q26778420-461BDEB4-3C02-4219-B1AE-FC1943E028EBQ26830603-17141622-A7D8-476A-AA70-8DEA0430818CQ27001119-1D52649E-E924-4A2E-BE6F-D7A8F1D662EBQ27315950-228A552A-090E-4B9A-BB20-826180DE639CQ28076564-DCBC5106-879E-4FCD-A1D1-84C4E49CA9B1Q28077939-38DDCDB8-CC2F-4DAC-BDAB-27093CD14D3EQ28079821-89386966-6C87-416B-A354-CEBD72E78B4CQ28542478-8C33B2ED-221A-4290-B900-25E8C21C6CF3Q28550695-1C79F1FE-7009-43E8-9DF6-CCC4CFF97920Q28727394-09671DF8-F8B5-4693-A7E7-2B0A621393BEQ30249553-710872EF-81EB-4693-BCB8-2D22A6B084F6Q30410153-2BA50478-A9EA-4C3F-952B-2965453B648FQ30413207-DEECCC64-F7BC-416E-BA09-9B2B41C8C70FQ30413968-1569AB17-38AB-4B08-8EB3-862EB1861679Q30437188-2678788D-D65E-4292-813D-1E84272A56B2Q30462673-9E5F6AA8-D1D7-4284-B20D-459F8FA4F0C7Q30694281-B1F89DDB-90D7-4209-AD71-739B5FB6791DQ30747587-624AA0B0-6AB8-4E5A-97BF-CEF9F585C6B7Q33624417-581E5437-4488-4A72-BD98-DD92F16D665CQ33893744-D5FDB3C9-6583-436C-AF0F-3B81B5886423Q34145251-6748BCA8-92D5-4230-B887-C71FA55AC1CFQ34377871-50C162E8-ED20-4F73-8B9A-F4CA48205128Q35060316-4581A3D7-1F9C-46D0-A080-1394DAC37E6FQ35144326-EC7FEA1F-AE05-4916-BF3D-835777B81230Q35195516-CB213AC1-B3BE-421B-A96D-644732D45960Q35738057-B2B99AB2-4412-45D8-846B-997B5AF003C6Q35834247-8DFA46D1-1127-4F05-9B5E-B4DB9C37BC43Q36062184-5F88C050-6342-46AE-8CE0-96F71B9B7823Q36386323-9C7C8042-4330-4AA5-91AE-37A3A5711990Q36594911-19B2EAE8-D5D3-4A19-8BBA-4ECF1902E20FQ36626038-F7F98D4A-726F-4629-90BC-E2F010A58AE6Q36690726-DE6825C3-3A5A-4134-8435-C48391CA9D08Q36702449-1F0C6E97-D823-4755-BCE2-05BC8BA1BA94Q36920020-22408F77-5ED3-40F4-8266-D80D796B679EQ37062793-1A1DFCFC-05D8-4FAC-B585-B8AD7A2408FDQ37242424-36CB86EB-9B94-4D18-9DB2-0B5AB7621A24Q37676119-FE1CFF20-ACDE-455B-9478-F6FF7C6A6214
P2860
All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
All Roads to Schizophrenia Lea ...... ated Dopamine D2High Receptors
@ast
All Roads to Schizophrenia Lea ...... ated Dopamine D2High Receptors
@en
type
label
All Roads to Schizophrenia Lea ...... ated Dopamine D2High Receptors
@ast
All Roads to Schizophrenia Lea ...... ated Dopamine D2High Receptors
@en
prefLabel
All Roads to Schizophrenia Lea ...... ated Dopamine D2High Receptors
@ast
All Roads to Schizophrenia Lea ...... ated Dopamine D2High Receptors
@en
P2860
P3181
P1476
All roads to schizophrenia lea ...... ed dopamine D2(high) receptors
@en
P2093
Philip Seeman
P2860
P304
P3181
P356
10.1111/J.1755-5949.2010.00162.X
P577
2011-04-01T00:00:00Z